Changeflow GovPing Healthcare & Life Sciences TruPulse Ablation Generator Safety with Thermoc...
Urgent Notice Added Final

TruPulse Ablation Generator Safety with Thermocool Catheter

Favicon for ansm.sante.fr ANSM Drug & Device Safety Alerts
Published
Detected
Email

Summary

ANSM issued safety notification R2608394 regarding a field safety corrective action by Biosense Webster Inc. for the TruPulse cardiac ablation generator (software version 2.7.0) when used with the Thermocool SmartTouch SF dual-energy catheter. Healthcare facilities using this equipment must review the manufacturer's safety communication dated March 30, 2026.

Published by ANSM on ansm.sante.fr . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

Biosense Webster Inc. initiated a safety action concerning the TruPulse ablation generator software version 2.7.0 used in combination with the Thermocool SmartTouch SF dual-energy catheter. ANSM is distributing this safety notice (Reference: R2608394) to all affected healthcare establishments. The manufacturer has issued a direct communication to concerned users with specific safety instructions.

Healthcare facilities with this equipment must download and review the manufacturer's letter dated March 30, 2026. Clinical staff should assess any impact on current ablation procedures and follow the manufacturer's guidance for continued safe use or corrective measures. Contact Biosense Webster directly for questions regarding implementation of the safety action.

What to do next

  1. Download and review the Biosense Webster Inc. safety letter from the provided PDF link
  2. Identify all TruPulse generators running software version 2.7.0 used with Thermocool SmartTouch SF catheters at your facility
  3. Contact Biosense Webster directly for guidance on any required corrective actions or procedure modifications

Archived snapshot

Mar 30, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

A+ A-

Information n° R2608394 destinée aux établissements de santé L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Biosense Webster Inc.

Les utilisateurs concernés ont reçu le courrier ci-joint.

Cette action de sécurité est enregistrée à l’ANSM sous le n° R2608394. Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité.

Téléchargez le courrier de la société Biosense Webster Inc (30/03/2026)

Get daily alerts for ANSM Drug & Device Safety Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from ANSM.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
ANSM
Published
March 30th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Substantive
Document ID
R2608394

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing 6221 Hospitals & Health Systems
Activity scope
Medical Device Safety Reporting Cardiac Ablation Procedures
Threshold
Healthcare establishments using TruPulse ablation generators with Thermocool SmartTouch SF dual-energy catheters
Geographic scope
France FR

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Topics
Healthcare Public Health

Get alerts for this source

We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!